> APP Pharmaceuticals ($APPX), which two weeks ago received FDA approval to make preservative-free Methotrexate at its manufacturing facility in Melrose Park, IL, has released 35,000 vials of Methotrexate Injection, USP, and 10,000 vials of preservative-free Methotrexate Injection, USP, which should soon be available to clinicians to ease shortage issues. Story
> Per its agreement with Pfizer ($PFE), Ranbaxy Laboratories ($RANBXY.NS) is selling a generic version of Lipitor in Germany, Italy, Sweden and the Netherlands. Story
> Endo Pharmaceuticals Holdings ($ENDP), maker of the Opana ER painkiller, will ask shareholders to approve a name change to Endo Health Solutions Inc. Release
> Merck KGaA ($MRK.DE) has donated to the Zambian Health Ministry 5 mobile labs to be used to detect counterfeit medications. Release
> Ann Arbor, MI.-based Rubicon Genomics, has selected Velesco Pharmaceutical Services, which has a 10,000 square foot manufacturing facility in nearby Kalamazoo, MI, to manufacture breast cancer diagnostics kits Rubicon is providing to Agendia, a molecular diagnostics company. Release
> Chemist Cheng Yi Liang, who worked for the FDA's Center for Drug Evaluation and Research, was sentenced to 5 years in prison for trading on insider information to make $3.78 million. Story